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Abstract
Background: Despite the importance of the human leukocyte antigen (HLA) gene locus in research and clinical practice,
direct HLA typing is laborious and expensive. Furthermore, the analysis requires specialized software and expertise which
are unavailable in most developing country settings. Recently, in silico methods have been developed for predicting HLA
alleles using single nucleotide polymorphisms (SNPs). However, the utility of these methods in African populations has not
been systematically evaluated.
Methodology/Principal Findings: In the present study, we investigate prediction of HLA class II (HLA-DRB1 and HLA-DQB1)
alleles using SNPs in the Wolaita population, southern Ethiopia. The subjects comprised 297 Ethiopians with genome-wide
SNP data, of whom 188 had also been HLA typed and were used for training and testing the model. The 109 subjects with
SNP data alone were used for empirical prediction using the multi-allelic gene prediction method. We evaluated accuracy of
the prediction, agreement between predicted and HLA typed alleles, and discriminative ability of the prediction probability
supplied by the model. We found that the model predicted intermediate (two-digit) resolution for HLA-DRB1 and HLA-DQB1
alleles at accuracy levels of 96% and 87%, respectively. All measures of performance showed high accuracy and reliability for
prediction. The distribution of the majority of HLA alleles in the study was similar to that previously reported for the Oromo
and Amhara ethnic groups from Ethiopia.
Conclusions/Significance: We demonstrate that HLA class II alleles can be predicted from SNP genotype data with a high
level of accuracy at intermediate (two-digit) resolution in an African population. This finding offers new opportunities for
HLA studies of disease epidemiology and population genetics in developing countries.
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Introduction
The human leukocyte antigen (HLA) locus, located on
chromosome 6p21.3, is the most polymorphic and gene-dense
region of the human genome [1]. HLA genes play important roles
in the immune system and have multiple alleles that show
extensive variation across human populations. The HLA locus has
been a focus for genomic research and clinical practice for several
reasons: (i) it is associated with susceptibility to or resistance against
several infectious, autoimmune and inflammatory diseases; (ii) it is
very informative in studies of human genetic diversity; and, (iii) it is
central to donor-recipient matching in tissue and organ trans-
plantation [2]. Understanding the HLA system in African
populations has unique advantages. Africa is the most genetically
diverse geographical region in the world and consequently, it
harbours diverse and novel HLA alleles such as the class II
DQA1*0403N [3], DPA1*010602 [4], DPB1*9401, DPB1*9501
[5], DPA1*010303, and DPA1*0303 [6] alleles. HLA alleles are
found to be associated with susceptibility and resistance to
infectious diseases including HIV/AIDS, tuberculosis, and malaria
that impose huge public health burdens in Africa [7,8]. HLA
studies have also yielded important insights into the role of
pathogens in driving HLA polymorphism. For example, a study
that analyzed 61 human populations across the world showed that
populations that have a greater burden of pathogens show higher
HLA diversity and that populations farther from Africa (geo-
graphic distance measured through landmasses from Ethiopia) are
characterized by lower HLA diversity [9]. Despite such interest in
HLA studies from diverse disciplines, direct typing of HLA genes is
time consuming and expensive. Analysis of the results and
assignment of HLA gene alleles requires special software and
expertise [10,11,12,13]. Of particular concern is the fact that most
of the resources needed for direct typing of HLA alleles are
inaccessible to research institutions and clinical centers in many
developing countries, including those in Africa.
The use and acceptance of single nucleotide polymorphism
(SNP) genotype data in the HLA region to predict HLA alleles is
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increasing, especially in non-African populations. This approach is
less expensive than classical HLA typing, and in some instances the
required SNP data may already have been generated through
high-throughput genotyping done for large-scale genomic studies.
Computational and statistical algorithms that have been developed
to predict HLA alleles using SNPs include: (i) a ‘tag SNP’ method
that predicts HLA alleles using up to three tagging SNPs that are
in strong linkage disequilibrium with HLA genes [14,15], (ii) an
identity-by-decent (IBD) algorithm for predicting HLA gene alleles
using SNP haplotypes and phased HLA data [16,17], (iii) a unified
framework for inferring HLA alleles using pedigree information,
known HLA types of some individuals, and the relationship
between SNP haplotyes and HLA alleles [18], (iv) an iterative
method for HLA allele prediction using unphased SNP data and
shared IBD segments between pairs of individuals [19], and (v) a
multi-allelic gene prediction (MAGPrediction) method for predicting
highly polymorphic gene alleles using unphased SNP genotype
data [20,21].
Despite promising reports of prediction performance of the
above in silico methods, which were developed and validated using
data from European populations, most have not been systemat-
ically evaluated in datasets generated from African populations.
Only the tag SNP method has been used on an African population
dataset (the YRI - Yoruba from Nigeria - in the HapMap dataset)
to construct a high resolution HLA and SNP haplotype map.
However, the approach has limitations for HLA inference because
HLA genes are highly polymorphic and several tag SNPs need to
be typed. Furthermore, two or three tag SNPs cannot usually
provide the resolution needed to identify rare HLA alleles that
have multiple haplotype backgrounds [16]. This problem becomes
more marked in African datasets because of weaker linkage
disequilibrium among neighboring loci [22,23]. More importantly,
for several reasons, informative tag SNPs that capture some of the
HLA variation in one African population cannot be used as
proxies for predicting HLA alleles in other African populations.
Firstly, African populations have wide genetic and haplotype
diversity [24,25]. Secondly, of the several alleles of an HLA gene
enumerated across global populations, only a sub-set is found in
any given population [26]. Finally, novel alleles present in one
population group may be absent in other population groups. In
summary, the high polymorphism of HLA genes, genetic diversity
among African populations and resource limitations in these
settings present important challenges to direct HLA typing and/or
the use of the same set of tag SNPs across different African
populations.
Here, we describe the accuracy and reliability of HLA
prediction from SNP data in an African population with the goal
of evaluating this as a simple, inexpensive, and accurate method of
determining HLA types in African populations in general. To
achieve this goal, we predicted the HLA class II DRB1 and DQB1
alleles in the Wolaita population from southern Ethiopian
population using genome-wide SNPs generated from a commer-
cial genotyping array. We also describe distributions of HLA-
DRB1 and HLA-DQB1 alleles in our sample using predicted and
directly typed HLA data, and compare the allele distributions with
available published data from two other Ethiopian ethnic groups,
the Amhara and the Oromo.
Results
Prediction
Demographic characteristics of the HLA typed individuals
included in the prediction (training and testing) were presented in
Table S1. A set of 19 SNPs (within the region from 32,514,144 to
32,582,075 bp) and 10 SNPs (within the region from 32,606,390
to 32,643,859 bp) were selected by the MAGPrediction model for
predicting HLA-DRB1 and HLA-DQB1 alleles, respectively. Of
these SNPs, three were within the HLA-DQB1 gene (Table S2).
Evaluation of Accuracy of Prediction
At intermediate (two-digit) resolution, the prediction probabil-
ities calculated by the model were high: 87.8% and 91.6% for
HLA-DRB1, and 87.4% and 85.4% for HLA-DQB1 in the test
and prediction sets, respectively. However, at high (four-digit)
resolution, the prediction probabilities were ,32% and the model
did not output any alleles. Below we describe only intermediate
resolution prediction results. The prediction accuracy of the model
was also high: 95.5% for HLA-DRB1 and 87.0% for HLA-DQB1
(Table 1). The flanking boundaries determined by the objective
function showed that SNPs in a region spanning 635–40 kb of
HLA-DRB1 and HLA-DQB1 genes were optimal for predicting the
respective HLA alleles (Fig. S1).
The accuracy of the prediction by the intermediate resolution
model was high. The sensitivity, specificity, positive predictive
value (PPV), and negative predictive value (NPV) of the model was
,100% for the majority of HLA-DRB1 alleles. The model also
has high diagnostic validity for HLA-DQB1: sensitivity (77.8–
100%), specificity (95.3–99.4%), PPV (77.4–92.7%), and NPV
(91.7–100%) (Table 2). The predicted and directly typed HLA
alleles had high level of agreement: k=0.95 (95% CI=0.91–0.98)
for HLA-DRB1 and k=0.83 (95% CI= 0.77–0.90) for HLA-
DQB1 (Table 3). The receiver operating characteristic (ROC)
curve showed that the model had ‘‘excellent’’ [27] discriminative
ability for HLA-DRB1 (area under the curve [AUC]=0.86,
SE= 0.07, 95% CI= 0.78–0.99). For HLA-DQB1, the model had
‘‘good’’ [27] discriminative ability (AUC=0.73, SE= 0.03, 95%
CI= 0.59–0.87) (Fig. 1). The proportion of individuals for which
both of the predicted HLA alleles (the HLA genotype) was correct
was 91% and 78% and those for which at least one of the two
alleles was correct was 100% and 98.9% for HLA-DRB1 and
HLA-DQB1, respectively. Next, a 10-fold cross-validation done in
WEKA [28] using two independent algorithms showed the average
accuracy of prediction of HLA-DQB1 and HLA-DRB1 to be 0.81
and 0.94 and the AUC to be 0.88 and 0.93, respectively (Table
S3).
HLA-DRB1 and DQB1 Allele Distributions in Three
Ethiopian Ethnic Groups
A total of 16 alleles (11 DRB1 and 5 DQB1) were identified in
the Wolaita ethnic group. Eleven of the 16 alleles had frequencies
greater than 5%. The allele frequencies were in Hardy-Weinberg
equilibrium. The three most frequently detected HLA-DRB1
alleles in the Wolaita were DRB1*15 (23.1%), DRB1*13 (19.0%),
and DRB1*01 (18.8%). The three most common HLA-DQB1
alleles were DQB1*06 (35.6%), DQB1*05 (21.9%), and DQB1*02
(20.6%). The distribution of HLA alleles in the three populations is
shown in Table 4. When considering the three Ethiopian ethnic
groups (Wolaita, Oromo and Amhara), there were 15 (10 DRB1
and 5 DQB1) common HLA allelic sub-types. In addition, one
Oromo individual had the DRB1*12 allele and one Wolaita
individual had the DQB1*01 allele. Of the 15 HLA alleles
common to the three groups, the differences in frequency of nine
were not statistically significant. However, significant frequency
differences were observed for the following alleles: the frequencies
of DRB1*01 and DQB1*05 were higher in the Wolaita (18.8%
and 21.9%) and Amhara (13.3% and 16.8%) than the Oromo
ethnic group (5.4% and 8.4%); the frequency of DRB1*15 was
higher and that of DRB1*07 and DQB1*02 was lower in the
HLA Allele Prediction in an African Population
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Wolaita (23.1%, 14%, and 20.6%) than the Oromo (12.1%,
21.7%, and 33.7%); and Amhara (10.7%, 20.4%, and 30.1%).
DRB1*04 was significantly less frequent in the Wolaita (6.6%)
than the Oromo (16.3%). The heterozygosity levels of DRB1 and
DQB1 in Wolaita were 0.86 and 0.76, respectively, and were
similar to those in the Amhara (0.86, and 0.75) and Oromo (0.84,
and 0.73). In Wolaita, the inbreeding coefficient of an individual
relative to the population (FIS =20.003) was not statistically
significant (P = 0.65).
Discussion
This study demonstrated high accuracy of two-digit HLA
prediction using a small set of SNPs in an Ethiopian population.
This suggests that HLA prediction may provide a simpler and less
expensive alternative to direct typing of HLA genes in an African
population. We were able to predict intermediate (two-digit)
resolution HLA-DRB1 and HLA-DQB1 alleles at accuracies of
95.5% and 87.0% using a set of 19 SNPs and 10 SNPs,
respectively. Of the 29 SNPs selected in our prediction, six (i.e.,
rs2516049, rs477515, rs660895, rs532098, rs1063355, rs660895)
belonged to the set of SNPs identified during construction or
validation of different in silico HLA prediction methods [14,16,20]
(Table S4). Compared to the prediction accuracy of the
MAGPrediction model in the European population dataset, its
accuracy in our dataset was higher for HLA-DRB1 and lower for
HLA-DQB1 at confidence threshold (CT) = 0 [20]. The sensitiv-
ity, specificity, PPV and NPV of our prediction was on average
98.2%, 99.4%, 96.3%, and 99.9% for 10 HLA-DRB1 alleles and
88.5%, 97.0%, 86.2% and 97.0% for six HLA-DQB1 alleles
common in our studied population. The levels of agreement (i.e.,
Table 1. Prediction probability and accuracy of predicting HLA-DRB1 and -DQB1 alleles.
Intermediate (2-digit) resolution High (4-digit) resolution
Prediction probability,
mean (S.D.) accuracy
Prediction probability,
mean (S.D.) Accuracy
HLA-DRB1
Test set 0.88 (0.17) 0.96 0.30 (0.17) NAa
Prediction set 0.92 (0.15) – 0.32 (0.21) NA
HLA-DQB1
Test set 0.87 (0.16 0.87 0.31 (0.11) NA
Prediction set 0.85 (0.16) – 0.31 (0.22) NA
aThe symbol NA means not available because prediction was not performed.
doi:10.1371/journal.pone.0040206.t001
Figure 1. Receiver operating characteristic curves of correct HLA allele predictions at different prediction probability cut-off points.
(A) HLA-DRB1, AUC= 0.86 (95% CI = 0.78–0.99), P = 0.001. (B) HLA-DQB1, AUC= 0.73 (95% CI = 0.59–0.87), P = 0.002.
doi:10.1371/journal.pone.0040206.g001
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k=95% and k=83% for HLA-DRB1 and HLA-DQB1, respec-
tively) between the predicted and experimentally determined HLA
alleles were ‘‘almost perfect’’ according to the classification of
strength of agreement by Landis and Koch [27]. The AUC of the
ROC curve showed that the model had reliable discriminatory
ability for both accurate and inaccurate predictions. Better
accuracy and specificity could be gained by increasing the CT
for the prediction probability. For example, as can be seen in
Fig. 1, increasing CT to 0.75 in case of HLA-DRB1 and to 0.85
in case of HLA-DQB1 improves both accuracy and specificity
with minimal loss in sensitivity.
While performance of the prediction at intermediate resolution
was robust, there was a sharp fall in accuracy for high resolution
HLA prediction. Therefore, this model is limited for clinical and/
or research applications that require four-digit resolution. As has
been suggested, imputation using population specific dense SNP
data may improve the prediction accuracy [21]. However, we
were unable to conduct imputation in the present study because of
the absence of appropriate reference sequence variation data. The
extensive HLA genetic diversity in African populations (for an
example please see Fig. S2) means there is a need to study
whether the SNPs selected in our samples can be transferred, and
the HLA prediction method applies to other African populations.
The findings showed that the distribution of the majority of
HLA alleles, and the level of heterozygosity at the HLA-DRB1
and HLA-DQB1 loci was similar among the three Ethiopian
ethnic groups. The present study and a previous one [29] also
showed that the frequencies of HLA-DQB1*02 (a risk allele for
podoconiosis) and HLA-DRB1*13 (a protective allele against
podoconiosis) in the Ethiopian population were among the highest
in Sub-Saharan Africa. HLA-DQB1*02 had the third highest
frequency in the Ethiopian ethnic groups following Burkina Faso’s
Fulani (DQB1*0201, 36.0%) and Central African Republic’s Aka
Pygmy group (DQB1*0201, 36.9%). The Fulani from Burkina
Faso and The Gambia share the distribution of other specific HLA
alleles closely with the Amhara and Oromo of Ethiopia [30].
Likewise, HLA-DRB1*1302, a rare allele in the majority of the
world’s populations, has the second and third highest frequencies
in the Ethiopian Amhara (17.3%) and Oromo (16.9%) following
Saudi Arabia (19.6%). The Ethiopian ethnic groups had the
Table 2. Sensitivity, specificity, positive predictive value and negative predictive value of the prediction in the test set at
intermediate (two-digit) HLA allele resolution.
Allele Observed (count) Predicted (count)
Correctly
Predicted (count) Sensitivity (%) Specificity (%) PPVa (%) NPVa (%)
HLA-DRB1
07 41 41 41 100 100 100 100
15 36 36 36 100 100 100 100
13 22 22 22 100 100 100 100
03 19 27 19 100 94.9 70.4 100
04 17 17 17 100 100 100 100
08 14 12 12 85.7 100 100 98.8
01 11 11 11 100 100 100 100
14 7 7 7 100 100 100 100
11 6 0 0 0 100 0 96.6
10 3 3 3 100 100 100 100
Overall mean (excluding HLA-DRB1*10, HLA-DRB1*11, and HLA-DRB1*14 that had
frequency ,0.05 in the training set)
98.2 99.4 96.3 99.9
HLA-DQB1
02 61 55 51 83.6 96.5 92.7 91.7
06 44 48 42 95.5 95.5 87.5 98.4
03 28 31 24 85.7 95.3 77.4 97.2
05 18 17 14 77.8 98.1 82.4 97.5
04 10 11 10 100 99.4 90.9 100
13 1 0 0 0 100 0 99.4
Overall mean (excluding HLA-DQB1*13 that had frequency ,0.05 in the training set) 88.5 97.0 86.2 97.0
The symbols PPV and NPV mean positive predictive value and negative predictive value, respectively.
doi:10.1371/journal.pone.0040206.t002
Table 3. Agreement between predicted and directly typed HLA alleles.
Total allele counts HLA alleles in agreement Kappa, k (95% CI) P value
HLA-DRB1 176 168 0.95 (0.91,0.98) ,0.0001
HLA-DQB1 162 141 0.83 (0.77,0.90) ,0.0001
doi:10.1371/journal.pone.0040206.t003
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highest observed frequencies of HLA-DRB1*13 compared with
other populations in Sub-Saharan Africa (http://www.
allelefrequencies.net/). Interestingly, HLA-DQB1*02 is implicated
in several autoimmune and infectious diseases [2]. The Fulani
mount a stronger humoral immune response to malaria evidenced
by higher levels of antibodies against several P.falciparum antigens,
and are less susceptible to the disease than other ethnic groups in
neighboring areas [31,32,33]. This suggests that the high
frequency of HLA-DQB1*02 observed among the Fulani may
be related to the enhanced immune reactivity reported in this
ethnic group [30]. Similarly the DRB1*13-DQB1*05 haplotype
was associated with protection against severe malaria in the
Gambian population and HLA-DRB1*13 was reported to be
associated with protection against persistent hepatitis B infection
[34]. It is estimated that malaria is endemic in three-quarters of
the landmass of Ethiopia predisposing over two-thirds of the
population to the disease [35]. The Amhara, Oromo and Wolaita
ethnic groups form 64% of the total population of Ethiopia [36],
and podoconiosis is common in regions predominated by these
ethnic groups [37,38,39]. Together, these data raise the hypothesis
that pathogen-driven selective forces, particularly malaria (be-
lieved to have exerted a selective pressure on the immune system
[40]), induced the high frequency of the HLA-DQB1*02 and
HLA-DRB1*13 alleles in the Ethiopian population.
In conclusion, we have demonstrated that HLA class II alleles
can be predicted with high accuracy at intermediate (two-digit)
resolution in an African population using SNP genotype data.
These findings strongly suggest that the prediction model for HLA
alleles described here is promising as an epidemiological tool for
studying HLA associated diseases, understanding the role of
pathogens in human HLA polymorphism, and population
screening programs involving HLA testing in African populations.
Materials and Methods
Ethics Statement
Ethics approval was obtained from ethics review committees of
the Medical Faculty of Addis Ababa University, AHRI/ALERT
and the Ethiopian Ministry of Science and Technology. Written
informed consent was obtained from all participants.
Datasets
Data were obtained from 297 unrelated individuals enrolled
into a genetic epidemiology study on podoconiosis (endemic non-
filarial elephantiasis [41,42]) from Wolaita zone, southern
Ethiopia. SNP genotyping was done by deCODE Genetics using
the Illumina Human610-Quad Bead Chip that contains more
than 620,000 SNPs. After quality filters that removed SNPs with
call rates ,95%, we extracted 3,537 SNPs in the extended HLA
region (chromosome 6:28,799,220–34,204,868) [43] to generate a
set of informative SNPs for HLA allele prediction. HLA-DRB1 and
HLA-DQB1 typing data generated using the high definition
LuminexH xMAPH technology, which analyses PCR-sequence
specific oligonucleotide (PCR-SSO) amplified DNA samples, was
also available in 188 subjects and was used to validate the HLA
allele predictions [11]. Finally, we compared HLA allele frequency
Table 4. Distribution of HLA-DRB1 and HLA-DQB1 alleles in the Wolaita, and comparison of their frequencies with the Ethiopian
Oromo and Amhara ethnic groups.
Allele count (%)a P value based on Chi-square test
Wolaita
(predicted and typed)
n =197
Oromob
n=83
Amharab
n=98
Wolaita
vs.
Oromo
Wolaita vs.
Amhara
Amhara
vs.
Oromo
HLA-DRB1
01 74 (18.8) 9 (5.4) 26 (13.3) ,0.0001 0.09 0.01
03 29 (7.4) 18 (10.8) 16 (8.2) 0.18 0.73 0.38
04 26 (6.6) 27 (16.3) 22 (11.2) 0.0004 0.05 0.16
07 55 (14.0) 36 (21.7) 40 (20.4) 0.02 0.05 0.77
08 24 (6.1) 9 (5.4) 16 (8.2) 0.76 0.35 0.31
10 6 (1.5) 4 (2.4) 6 (3.1) 0.47 0.21 0.71
11 6 (1.5) 4 (2.4) 5 (2.6) 0.47 0.38 0.93
13 75 (19.0) 37 (22.3) 42 (21.4) 0.38 0.49 0.84
14 8 (2.0) 1 (0.6) 2 (1.0) 0.22 0.37 0.66
15 91 (23.1) 20 (12.1) 21 (10.7) 0.003 0.0003 0.69
12 0 1 (0.6) 0 NAc NA NA
HLA-DQB1
02 77 (20.6) 56 (33.7) 59 (30.1) 0.001 0.01 0.46
03 69 (18.5) 35 (21.1) 40 (20.4) 0.48 0.57 0.88
04 12 (3.2) 8 (4.8) 5 (2.6) 0.36 0.66 0.25
05 82 (21.9) 14 (8.4) 33 (16.8) 0.0002 0.15 0.02
06 133 (35.6) 53 (31.9) 59 (30.1) 0.41 0.19 0.71
01 1 (0.3) 0 0 NA NA NA
aThe denominator for each proportion is total number of chromosomes = 2 n.
bSource: HLA Nomenclature, http://www.allelefrequencies.net/.
cThe symbol NA means P values were not calculated because HLA-DRB1*12 and HLA-DQB1*01 were absent in Oromo and Amhara.
doi:10.1371/journal.pone.0040206.t004
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distributions between the population group in our dataset and
unrelated and apparently healthy children of Oromo (n= 83) and
Amhara (n= 98) ethnicity from central Ethiopia (http://www.
allelefrequencies.net/). The mean age of the Oromo and Amhara
subjects was 8.2 years, and ranges between 4 and 12 years [29,44].
The Multi-Allelic Gene Prediction Model
For prediction, we selected the Multi-allelic Gene Prediction
model (MAGPrediction - http://qge.fhcrc.org/MAGprediction/)
[20,21] because it includes important factors that influence
accurate HLA allele prediction including ethnicity, genotyping
platforms and use of both experimentally genotyped and imputed
SNPs. A more detailed description of the model can be found in Li
et al, 2011 [20]. In brief, MAGPrediction is a general method for
predicting highly polymorphic gene alleles using unphased SNP
genotype data. Using a training dataset, the model selects
informative non-redundant SNPs by employing a combined
forward selection and backward elimination scheme, which starts
with SNPs within an HLA gene and gradually extends to flanking
regions. This procedure selects a boundary where the objective
function achieves a minimum value while maintaining maximum
accuracy. The SNP selection process is evaluated by an objective
function (the negative log likelihood of predictive probabilities).
The model calculates a range of prediction probabilities
constructed based on Bayesian probability theorem, each
probability corresponding to one possible pair of alleles for each
individual at CTs supplied by the user. The original model was
trained and validated using European population data from the
Fred Hutchinson Cancer Research Center (FHCRC). The
predictive model achieved intermediate and high resolution
accuracies ranging, respectively, from 97–100% and 95–97% for
HLA-A, from 96–98% and 94–96% for HLA-B, 98% and 97–
98% for HLA-C, from 93–97% and 79–96% for HLA-DRB1, and
from 97–98% and 83–95% for HLA-DQB1 [20,21].
Data Analysis
Based on the MAGPrediction program, we used predicted
alleles obtained at the highest prediction probability, irrespective
of its value, and we assumed a CT of 0, meaning all samples were
predicted. Our training set included the SNP genotype and HLA
alleles of 94 randomly selected individuals, of whom 87 and 77 had
high resolution (i.e., amino acid level variation or four-digit
resolution) HLA-DRB1 and HLA-DQB1 data, respectively. Using
the training set the model selected a set of SNPs as informative
markers for HLA-DRB1 and HLA-DQB1 allele prediction. Using
these SNPs, we predicted HLA-DRB1 and HLA-DQB1 alleles in
a test set comprising 94 individuals of whom 92 had both SNP
genotypes and high-resolution HLA-DRB1 and HLA-DQB1
alleles. The intermediate-resolution (i.e., allelic group designation
or two-digit resolution) HLA allele nomenclature was obtained by
merging high-resolution HLA alleles with identical allele groups at
the first two digits (http://hla.alleles.org/nomenclature/) [45].
Performance of the prediction model was evaluated in the test
set by comparing predicted HLA alleles with experimentally
determined alleles using the LuminexH xMAPH technology using
multiple criteria as follows: (i) accuracy (i.e., the overall overlap
between the predicted and observed HLA-DRB1 and HLA-
DQB1 alleles), sensitivity (i.e., proportion of observed HLA alleles
that were correctly predicted), specificity (i.e., for a specific allele,
proportion of observed alleles that were different from the allele
and different from that specific allele based on prediction), PPV
(proportion of predicted specific HLA alleles that were actually
observed), and NPV (proportion of predicted alleles negative for a
specific HLA allele that were actually observed to be negative for
the specific allele); (ii) a reliability analysis that tested the level of
agreement between allele assignments by the model and the
reference using Cohen’s kappa statistic; and (iii) evaluation of the
ability of the model to be discriminative between correctly and
incorrectly predicted alleles using an ROC curve. ROC curves
plot the relationship between sensitivity (true positive fraction), on
the y-axis, and 1-specificity (false positive fraction) on the x-axis,
for different cut-off levels of test positivity, which in this case is a
likelihood assigned by the model when predicting each individual’s
HLA alleles to indicate the model’s estimate of accuracy. The
AUC of the ROC curve was determined to provide the probability
the model will assign higher prediction likelihood to HLA alleles
that were correctly predicted than to those that were not. The
AUC and its standard error (SE) were estimated using a
nonparametric approach [46]. Further validation of the prediction
was done using a 10-fold cross validation method (i.e., a model
that splits the data into 10 equal sized pieces, and iteratively trains
on 9 pieces and tests on the remainder and outputs the average)
using two independent prediction algorithms (Random forest and
J48) as implemented in WEKA, a machine learning algorithm for
data mining tasks.
After evaluating performance of the prediction model, we
applied the set of SNPs selected by the model to predict HLA
alleles in an independent prediction set comprising 109 individuals
with SNP data and no HLA allele data. Next, we compared HLA-
DRB1 and HLA-DQB1 allele frequencies in a combined dataset
(n = 197) comprising Wolaita ethnic individuals in the prediction
set (n = 109) and previously HLA typed controls free of
podoconiosis in the training set (n = 88) with those previously
reported in apparently healthy children of Oromo (n= 83) and
Amhara (n= 98) ethnicity from semi-urban parts of Asela town,
Arsi, central Ethiopia (http://www.allelefrequencies.net/) [29,44].
Individuals with podoconiosis (an HLA associated disease [42])
were excluded to minimize bias in allele frequency. Data were
analyzed using SPSS version 19. Statistical significance was tested
using the chi-square test and level of significance was set at 0.05.
Expected heterozygosity was calculated using FSTAT version
2.9.3.2 [47].
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